ONCOZENGE AB
ONCOZENGE AB
Share · SE0015504097 · A2QNQR (XSTO)
Overview
No Price
Closing Price XSTO 09.12.2025: 6,80 SEK
12.12.2025 07:07
Current Prices from ONCOZENGE AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
8LY.F
EUR
12.12.2025 07:07
0,62 EUR
-0,01 EUR
-2,22 %
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ONCOZ.ST
SEK
09.12.2025 08:44
6,80 SEK
0,85 SEK
+14,29 %
Share Float & Liquidity
Free Float 58,49 %
Shares Float 6,96 M
Shares Outstanding 11,89 M
Company Profile for ONCOZENGE AB Share
OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden. OncoZenge AB (publ) is a subsidiary of Moberg Pharma AB (publ).
Get up to date insights from finAgent about ONCOZENGE AB

Company Data

Name ONCOZENGE AB
Company OncoZenge AB (publ)
Website https://www.oncozenge.se
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A2QNQR
ISIN SE0015504097
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Stian Kildal
Market Capitalization 82 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Gustavslundsvagen 34, 167 51 Bromma
IPO Date 2021-02-12

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB ONCOZ.ST
Frankfurt 8LY.F
More Shares
Investors who hold ONCOZENGE AB also have the following shares in their portfolio:
GROUPE BERKEM     EO 2,25
GROUPE BERKEM EO 2,25 Share
JPMorgan SmartRetirement Blend 2035 Fund Class R6
JPMorgan SmartRetirement Blend 2035 Fund Class R6 Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025